LANXESS and Advent International complete foundation of industry leading Engineering Materials joint venture

Cologne

Specialty chemicals company LANXESS and private equity investor Advent International (“Advent”) have completed the formation of their engineering materials joint venture effective April 1, 2023. The new joint venture is the result of the combination of DSM’s Engineering Materials business and LANXESS’s former High Performance Materials business.

LANXESS holds about 40 percent of the joint venture, Advent about 60 percent. LANXESS also received a cash payment of around EUR 1.3 billion on March 31. LANXESS is using this mainly to reduce its debt and thus to strengthen its balance sheet.

As financial support for the joint venture, LANXESS will be providing a loan of EUR 200 million.

Information for editors:
All LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com. Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

You can find further information concerning LANXESS chemistry at http://lanxess.com/en/Media/Stories.

MORE ABOUT THIS TOPIC

PRESS RELEASE
PIR insulation panel, aluminium-laminated

LANXESS sharpens flame-retardant portfolio for rigid PU and PIR insulation

September 22, 2026
PRESS RELEASE
Funny portrait of a welsh corgi pembroke dog showering with shampoo.  Dog taking a bubble bath in grooming salon.

LANXESS at the SEPAWA Congress 2026

September 22, 2026
PRESS RELEASE
Vulkanox 4060

Sustainable Tire Protection: LANXESS Launches New Anti-Aging Agent as an Alternative for 6PPD

September 08, 2026
PRESS RELEASE
LANXESS manufactures an extensive product portfolio of lubricants. It includes additives and additive systems, synthetic base fluids and ready-to-use lubricants. 

LANXESS and KRAHN Chemie to Showcase Metal Working Fluid Solutions at Lubricant Expo Europe 2026

September 08, 2026
PRESS RELEASE
Woman working in Laboratory Kromm DL14

Saltigo showcases its phosgenation expertise and peptide synthesis reagents at CPHI Milan

September 07, 2026